Efficacy and Safety of CD5024 1% in Acne Vulgaris
Clinical trial NCT03034460 · COMPLETED
Trial details
- NCT number
- NCT03034460
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-25
- Primary completion
- 2016-11-02
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.